Difficulty: Medium
Average Score: 85%
Practice
Which of the following agents is the precursor of dopamine?
Correct answer
B
Rationale
In pharmacology, understanding the precursors of neurotransmitters is crucial for comprehending drug mechanisms and therapeutic effects. In this case, the correct answer is B) Levodopa. Levodopa is the precursor of dopamine and is commonly used in the treatment of Parkinson's disease to increase dopamine levels in the brain. Dopamine cannot be administered directly as it does not cross the blood-brain barrier, so Levodopa is used instead.
Now, let's explore why the other options are incorrect:
A) Bromocriptine is a dopamine agonist, not a precursor of dopamine.
C) Selegiline is a monoamine oxidase inhibitor and does not directly influence dopamine precursors.
D) Amantadine is an antiviral agent that also has dopaminergic effects but is not a precursor of dopamine.
Educationally, this question highlights the importance of knowing the pharmacological properties of medications used in neurological conditions. Understanding the relationship between Levodopa and dopamine provides insight into how drugs can modulate neurotransmitter levels to achieve therapeutic outcomes. This knowledge is essential for healthcare professionals involved in managing patients with Parkinson's disease and other conditions involving dopamine dysregulation.
Now, let's explore why the other options are incorrect:
A) Bromocriptine is a dopamine agonist, not a precursor of dopamine.
C) Selegiline is a monoamine oxidase inhibitor and does not directly influence dopamine precursors.
D) Amantadine is an antiviral agent that also has dopaminergic effects but is not a precursor of dopamine.
Educationally, this question highlights the importance of knowing the pharmacological properties of medications used in neurological conditions. Understanding the relationship between Levodopa and dopamine provides insight into how drugs can modulate neurotransmitter levels to achieve therapeutic outcomes. This knowledge is essential for healthcare professionals involved in managing patients with Parkinson's disease and other conditions involving dopamine dysregulation.